"Stereotactic body radiotherapy" trang 1 - tải miễn phí từ tailieuXANH
Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases

Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases
10    46    0
A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: The STEREO POSTOP GORTEC 2017-03 trial

A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: The STEREO POSTOP GORTEC 2017-03 trial
10    63    0
Oligometastases from prostate cancer: Local treatment with stereotactic body radiotherapy (SBRT)

Oligometastases from prostate cancer: Local treatment with stereotactic body radiotherapy (SBRT)
10    109    0
Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial

Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial
9    49    0
Comparing conVEntional RadioTherapy with stereotactIC body radiotherapy in patients with spinAL metastases: Study protocol for an randomized controlled trial following the cohort multiple randomized controlled trial design

Comparing conVEntional RadioTherapy with stereotactIC body radiotherapy in patients with spinAL metastases: Study protocol for an randomized controlled trial following the cohort multiple randomized controlled trial design
10    46    0
Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): A randomized controlled trial

Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): A randomized controlled trial
11    40    0
A phase III randomized-controlled, singleblind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)

A phase III randomized-controlled, singleblind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)
9    55    0
The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): Patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases

The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): Patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases
11    68    0
Alpha-fetoprotein normalization as a prognostic surrogate in small hepatocellular carcinoma after stereotactic body radiotherapy: A propensity score matching analysis

Alpha-fetoprotein normalization as a prognostic surrogate in small hepatocellular carcinoma after stereotactic body radiotherapy: A propensity score matching analysis
8    56    0
Predictive factors for survival following stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumour thrombosis and construction of a nomogram

Predictive factors for survival following stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumour thrombosis and construction of a nomogram
11    173    1
Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4–B1: A pilot study

Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4–B1: A pilot study
12    61    1
Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases

Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases
9    44    0
Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
8    81    0
A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
9    127    0
Intratumoural renal cell carcinoma haemorrhage following stereotactic radiotherapy: A case report

Intratumoural renal cell carcinoma haemorrhage following stereotactic radiotherapy: A case report
5    47    0
Choice of immobilization of stereotactic body radiotherapy in lung tumor patient by BMI

Choice of immobilization of stereotactic body radiotherapy in lung tumor patient by BMI
9    44    0
Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer

Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer
8    66    0
A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)

A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)
8    51    0
Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors

Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors
10    69    0
Rib fracture after stereotactic radiotherapy for primary lung cancer: Prevalence, degree of clinical symptoms, and risk factors

Rib fracture after stereotactic radiotherapy for primary lung cancer: Prevalence, degree of clinical symptoms, and risk factors
7    55    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.